Oak Point Partners, Inc. acquired the remnant assets of the Unigene Laboratories, Inc. Bankruptcy Estate in October 2016.
On July 2, 2013, Unigene filed a voluntary petition for relief under chapter 7 of the Bankruptcy Code in the United States Bankruptcy Court for the District of New Jersey, assigned Case No. 13-24696. On July 8, 2013, a Trustee was appointed to administer the remaining assets of the Bankruptcy Estate. Oak Point Partners, Inc. acquired the remnant assets of the Unigene Laboratories, Inc. Bankruptcy Estate in October 2016.
Unigene was a biopharmaceutical company that designed and manufactured peptide-based therapeutics.
Unigene also operated as Unigene Biotechnologies and Unigene Therapeutics
The former headquarters of Unigene was located in Boonton, NJ, and also had corporate addresses in Boonton and Fairfield, NJ.
Funds or Proceeds owed to Unigene Laboratories, Inc.
Inquiries regarding overpayments, refunds, unclaimed or undeliverable funds or proceeds owed to Unigene Laboratories, Inc., Unigene Biotechnologies, or Unigene Therapeutics may be directed to Oak Point Partners at:
Oak Point Partners, Inc.
P.O. Box 1033
Northbrook, IL 60065-1033
For questions or additional information please contact Janice Alwin at 847-577-1374. Requests for reasonable referral or finder fees for discovered remnant assets will be considered.
About Oak Point Partners
Oak Point Partners is a private investment firm specializing in the purchase of remnant assets. Oak Point Partners has completed purchases of the remaining known and unknown assets in hundreds of Chapter 11 and Chapter 7 bankruptcy cases. . Purchases include assets of Buffets Restaurants Holdings, Inc., Comdisco, Inc., and Velocity Express Corporation. Click here for a listing of Oak Point owned estates.
The information contained in this website is for general information purposes only and should not be relied upon without further inquiry or diligence. We make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, or suitability with respect to the information contained or services offered on the website for any purpose.